[DISCLOSURE] Pharma Research Products (214450) said on Oct. 11 that it has obtained a patent for thermo-sensitive hydrogel composition with nucleic acid and chitosan, for the purpose of new product development.
[DISCLOSURE] Pharma Research Products (214450) said on Oct. 11 that it has obtained a patent for thermo-sensitive hydrogel composition with nucleic acid and chitosan, for the purpose of new product development.
Editor’s picks
more
More from Headlines